Viewing nowDairid Tablet (Glimepiride)
Glimepiride 2mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

MFDS item code 200703797 · Notified 2007.04.03 · Insurance code 657800190
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used as an adjunct treatment to improve blood glucose control in patients with type 2 diabetes. It can be administered alone or in conjunction with meal therapy and exercise, and may be combined with other oral hypoglycemics or insulin if necessary for more effective blood sugar control. Particularly, it can be used in conjunction with metformin when glucose control is difficult with sulfonylureas or metformin monotherapy. This medication helps manage blood sugar levels, assisting in diabetes treatment.
The dose should be adjusted individually for each patient. Swallow without chewing with at least 1/2 glass of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received medication, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have shown better metabolic control when the dose was increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose-equivalence relationship between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the method described under Initial dose. That is, start with 1 mg daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previously administered medicine should be taken into consideration. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia is promptly controlled by immediately consuming sugar. Hypoglycemia may recur even after it has been successfully managed initially during treatment with a sulfonylurea. Therefore, patients should be monitored carefully. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization is sometimes necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal, and start insulin at a low dose, increasing it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin dosage should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, the addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level can be achieved by adjusting the dose of each medicine. However, efforts should be made to identify the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia when this medicine is administered concomitantly with metformin, and the risk may increase. Appropriate caution should be exercised.
This medication should not be used in patients with type 1 diabetes or those in a state of diabetic ketoacidosis or coma. It should not be administered to patients with allergies to this drug, its components, or to sulfonylureas and sulfonamide drugs. There is no experience using this medication in patients with severe hepatic or renal impairment, thus switching to insulin therapy is generally recommended. Pregnant or potentially pregnant women, and nursing mothers should not use this medication. In patients with severe infections or those before and after surgery, or after serious trauma, it is advisable to administer insulin therapy. Caution is required in cases of gastrointestinal issues such as diarrhea or vomiting, as there is a risk of hypoglycemia due to poor nutrient absorption. This medication contains lactose, so individuals with lactose intolerance or specific genetic metabolic disorders should not take it. During the first week of treatment, the risk of hypoglycemia is high, so careful monitoring of blood glucose is necessary. Particularly in the elderly, patients who have difficulty cooperating, those with poor nutritional status, those who have irregular eating habits, and those whose exercise and carbohydrate intake are not balanced, caution should be exercised. Patients who consume alcohol frequently or skip meals and those with impaired renal or liver function may also have an increased risk of hypoglycemia. Caution is also required in patients with other endocrine disorders, those who overdose on medication, and those taking multiple medications. This medication contains yellow coloring agents, so individuals allergic to this ingredient should use it cautiously. When taking this medication, one should be well aware of hypoglycemia symptoms, and if symptoms occur, they should immediately consume sugars to manage their blood sugar levels. Symptoms of hypoglycemia can include headaches, severe hunger, nausea, vomiting, fatigue, sleep disturbances, anxiety, aggression, decreased concentration, reduced agility or activity, depression, confusion, speech disturbances, aphasia, visual disturbances, tremors, partial paralysis, sensory alterations, dizziness, weakness, loss of self-control, temporary mental confusion, drowsiness, bradycardia, sweating, cold clammy skin, tachycardia, hypertension, palpitations, angina, cardiac arrhythmia, blurred vision, upper abdominal fullness or pressure. Severe cases may lead to loss of consciousness or seizures, thus immediate medical assistance is required. Moreover, gastrointestinal disturbances, liver function abnormalities, reduced blood cell count, and allergic reactions may occasionally occur, so any unusual symptoms should be reported to a doctor immediately. This medication should be combined with dietary therapy and exercise for effective blood glucose control, and it is important to take it regularly. When receiving treatment at another hospital while taking this medication, always inform the healthcare provider about the diabetes condition and medication usage. In stress situations such as surgery, infections, or trauma, a temporary switch to insulin therapy may be necessary. Dosage should begin at a low level, and effects should be confirmed through blood sugar and urine tests, adjusting as necessary. At the beginning of treatment or when changing medications, careful attention is required as hypoglycemia or hyperglycemia symptoms may affect driving or operating machinery. This medication is metabolized in the liver, so caution is needed regarding interactions when taken with other drugs that affect liver metabolism. Concurrent use with drugs that enhance the hypoglycemic effect may increase the risk of hypoglycemia. Conversely, using drugs that reduce the hypoglycemic effect may make glycemic control difficult. Certain medications like beta-blockers may obscure hypoglycemia symptoms, so caution is advised. Alcohol consumption can also affect blood sugar control, so careful attention should be paid. In cases of overdose, severe hypoglycemia can occur, requiring immediate emergency measures such as inducing vomiting, blocking drug absorption, or administering glucose injections. After excessive dosing, the patient's condition should be closely monitored for at least 24-48 hours. This medication should be kept out of the reach of children, stored tightly sealed in its original container. Pregnant or nursing women should abstain from taking this medication, and those planning a pregnancy should consult a doctor. Safety and efficacy for children under 18 have not been established, so it is best not to use it for this population. The elderly may experience reduced renal function, so dosing should be adjusted and monitored carefully.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorder, anxiety, aggressiveness, decreased concentration, decreased agility or drive, depression, confusion, speech abnormalities, aphasia, visual impairment, tremor, incomplete paralysis, sensory abnormalities, dizziness, weakness, loss of self-control, temporary mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and damp skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, biliary secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, dyspnea, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitivity reactions of the skin, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, arthralgia, dyspepsia, facial edema, erectile dysfunction, facial flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and light, at a temperature of 1 to 30 degrees Celsius. Storing it this way will help maintain its effectiveness.
Green rectangular tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Hana Pharmaceutical Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.